Category: Medications - Page 2

Morning Coffee and Levothyroxine: How to Space Doses for Better Absorption

Posted By John Morris    On 17 Jan 2026    Comments (9)

Morning Coffee and Levothyroxine: How to Space Doses for Better Absorption

Coffee can reduce levothyroxine absorption by up to 57%, leading to persistent hypothyroid symptoms. Wait 60 minutes after taking your pill before drinking coffee, or switch to liquid levothyroxine for reliable absorption without timing restrictions.

READ MORE
Managing Therapeutic Equivalents in Combination Drugs: Dose Differences Explained

Posted By John Morris    On 16 Jan 2026    Comments (10)

Managing Therapeutic Equivalents in Combination Drugs: Dose Differences Explained

Therapeutic equivalence in combination drugs isn't guaranteed just because two pills have the same name and dose. Learn why different formulations, inactive ingredients, and dose interactions can change outcomes - and how to avoid dangerous substitutions.

READ MORE
Batch Release Testing: Final Checks Before Pharmaceutical Distribution

Posted By John Morris    On 9 Jan 2026    Comments (14)

Batch Release Testing: Final Checks Before Pharmaceutical Distribution

Batch release testing is the final safety check for every pharmaceutical batch before distribution. It ensures drugs meet strict standards for potency, purity, and safety-preventing harmful products from reaching patients.

READ MORE
Questions to Ask Your Pharmacist About Medication Interactions

Posted By John Morris    On 4 Jan 2026    Comments (12)

Questions to Ask Your Pharmacist About Medication Interactions

Medication interactions can cause serious harm-but most patients never ask their pharmacist about them. Learn the 10 critical questions to ask to avoid dangerous drug, food, and supplement reactions.

READ MORE
Switching from Warfarin to a DOAC: What You Need to Know About Side Effects and Safety

Posted By John Morris    On 1 Jan 2026    Comments (13)

Switching from Warfarin to a DOAC: What You Need to Know About Side Effects and Safety

Switching from warfarin to a DOAC can reduce bleeding risks and eliminate frequent blood tests, but timing, kidney function, and patient selection are critical. Learn the safe steps, side effects, and who should avoid this switch.

READ MORE
Stability Testing Requirements: Temperature and Time Conditions for Pharmaceutical Products

Posted By John Morris    On 31 Dec 2025    Comments (0)

Stability Testing Requirements: Temperature and Time Conditions for Pharmaceutical Products

Stability testing ensures pharmaceutical products remain safe and effective over time. Learn the exact temperature and time conditions required by ICH Q1A(R2), how regulators interpret failures, and why even small deviations can trigger recalls.

READ MORE
Antiseizure Medications and Generic Substitution: Risks and Best Practices

Posted By John Morris    On 28 Dec 2025    Comments (10)

Antiseizure Medications and Generic Substitution: Risks and Best Practices

Generic antiseizure medications can save money, but for many patients, switching brands can trigger seizures or side effects. Learn the risks, which drugs are most dangerous to substitute, and how to protect your treatment plan.

READ MORE
Nitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts

Posted By John Morris    On 26 Dec 2025    Comments (13)

Nitrosamine Contamination in Generic Drugs: Recent Recalls and Regulatory Shifts

Nitrosamine contamination in generic drugs has triggered dozens of recalls since 2018. Learn which medications were affected, how these carcinogenic impurities form, and how the FDA's response has evolved to balance safety with supply stability.

READ MORE
How Generics Shape Global Healthcare Spending and Economic Stability

Posted By John Morris    On 25 Dec 2025    Comments (12)

How Generics Shape Global Healthcare Spending and Economic Stability

Generics keep global healthcare spending in check by cutting drug prices by up to 95%. They’re essential in high-income countries and life-saving in low-income ones, but adoption varies widely due to policy, access, and innovation.

READ MORE
Contamination Issues in Generic Drugs: Recent Cases and How to Prevent Them

Posted By John Morris    On 23 Dec 2025    Comments (11)

Contamination Issues in Generic Drugs: Recent Cases and How to Prevent Them

Recent contamination cases in generic drugs-including NDMA in valsartan and benzene in Mucinex-reveal serious safety gaps. Learn how these failures happen, which drugs are at risk, and what you can do to protect yourself.

READ MORE